The structures of OF4949-I, II, III and IV were identified by analysis of the products of their chemical degradation and by 1H NMR, 13C NMR, and mass spectrometry. These compounds were new cyclic peptides containing diphenyl ether as a chromophore.
OF4949-I,
II, III and IV are inhibitors of aminopeptidase B from Ehrlich ascites carcinoma cells, and are produced by a fungus, Penicillium rugulosum OF4949. We reported on the taxonomy of the organism, and on the fermentation, isolation, and physico-chemical and biological properties of these compounds.1) Physico-chemical data on the four components showed that they were water-soluble amphoteric peptides with similar structures. This paper deals with the structural elucidation of these four compounds.
Results
The molecular formula of I was identified as C23H26N4O8 and that of II, C22H24N4O8, judging from elemental analysis and secondary ion mass spectrometry (SI-MS).1)
In the 1H NMR data for II in ND4OD (Table 1) , the signals at 3 6.74, 6.67 and 5.78 indicated the presence of a tri-substituted benzene ring, and the signals at 5 7.41, 7.22, 7.05 and 6.85 indicated the presence of a di-substituted benzene ring. The signals at 5 4.46, 3.36 and 2.65 showed an AMX system, and those at S 3.67, 2.88 and 2.76 an ABX system, which suggested the presence of two similar carbon chains, both with -CCH2CHC-. The 1H NMR spectrum of I corresponded to that of II, the only difference being the signal at 8 3.93, which we attributed to a methoxy group in I (Table 1) .
The 13C NMR spectrum of II in ND4OD showed 22 well-defined carbon signals including two methylene carbons, four methine carbons (one of these four an aliphatic carbon bound to an oxygen function), four carbonyl carbons, and twelve carbons in two benzene rings, including five singlets and seven doublets (Table 2) . These data are consistant with those from 1H NMR studies of II. The 13C NMR spectrum of I corresponded well to the signals of II except for one quartet signal at 3 56 .7 (Table 2) .
Amino acid analysis of the acid hydrolysate of I disclosed three unusual amino acids, A, B, and Structure of A The molecular formula of A was C,H,NO,.
Its 'H NMR and 13C NMR spectra indicated the presence of one alcoholic hydroxyl group, one free amino group, and two free carboxylic groups. The gas chromatography mass spectrometry (GC-MS) spectrum of the trimethylsilyl (TMS) derivative of A was in agreement with that of authentic (3-hydroxyaspartic acid:
The L-configuration uration was ( NHTMS assigned to A with data on the specific rotation. We concluded that the absolute configuration of A was the L-erythro (1S, 2R) form by direct comparison with authentic racemic erythro-(ihydroxyaspartic acid synthesized from glycine and glyoxalate2) using HPLC andTLC. To confirm the structure of B2i the diphenyl ether was cleaved with sodium in liquid ammonia.
Two chromophoric fragments resulting from the reductive cleavage of B2 were identified to be Ltyrosine and O-methyl-L-tyrosine by HPLC and TLC. The configurations of these two amino acids were found to be the L-form by the method of KINOSHITA et a1.3)
Next, a synthetic study was done to locate the ether bond and methoxy group in the diphenyl ether moiety of B2. The synthesis of B2 was based on the coupling of tert-butyloxycarbonyl(Boc)-3-bromo-4-methoxyphenyalanine methyl ester (4) and Boc-L-tyrosine methyl ester (6) by the Ullmann reaction (Chart 1). The synthesized componuds 7, 8 and 9 were identical to Boc-B2-methyl ester, B2-methyl ester, and natural B2, respectively, in HPLC and TLC. Consequently, B2 was identified as 4-methylisodityrosine, and B3 as isodityrosine, as shown below. groups), and 7.64 (amino group), and by those for I, with a pKa' of 3.12 (carboxyl group) and 7.56
(amino group). Similarly, F had properties similar to those of D except for having a methoxy group instead of a phenolic hydroxyl group. Thus we decided that F was a demethylated derivative of D.
To locate the free amino group in I and II, they were reacted with 2,4-dinitrofluorobenzene to
give their dinitrophenyl (DNP) derivatives. Upon hydrolysing DNP-I (or DNP-II), we found that only B., (or B,) was modified with DNP, and that A was unchanged. The acid hydrolysis of DNP-I followed by cleavage with sodium in liquid ammonia gave L-tyrosine. Thus, the free amino group of I was derived from the amino group of the O-methyl-L-tyrosine moiety of B2.
To decide on the location of the free carboxyl group, I-methyl ester (or II-methyl ester) was reduced with lithium borohydride (LiBH4) and then hydrolyzed with HCl to give reduced B2 (or reduced B1) and unchanged A. This result suggested that the free carboxyl group was also located on the B2 (or B1) fragment and that one of the two carboxyl groups on (3-hydroxyaspartic acid was substituted by a carboxamide group in I and II.
Compound C was treated with MeOH -HCl to afford C-trimethyl ester, which indicated that C is a linear peptide resulting from the cleavage of one of the two peptide bonds in the cyclic peptide D.
DNP-C was hydrolyzed with HCl to afford DNP-B2 and unchanged A. The cleavage of C with sodium in liquid ammonia gave L-tyrosine but no O-methyl-L-tyrosine. The results of these reactions were sufficient evidence to allow us to conclude that the peptide bond of C was between the a-amino group of /3-hydroxy-L-asparagine and the carboxyl group of O-methyl-L-tyrosine moiety, and that the terminal aromatic amino acid of C was L-tyrosine. Another chromophoric linear peptide E was determined
Chart 2. Controlled hydrolysis of OF4949-1 and II. to be a demethylated derivative of C by spectrometric analysis with the aid of the reactions above.
Consequently, C and E have the structures shown below.
The only remaining uncertainty about the structures of I and II was the linkage between /3-hydroxyasparagine and B1 (or B2).
Both structures shown here were theoretically possible. We decided between them as follows.
F-Dimethyl ester was reduced with LiBH4 to give F-diol and then hydrolyzed with HC1 to afford reduced j3-hydroxyaspartic acid. The GC-MS spectrum of the TMS derivative of the (3-hydroxyaspartic acid (see Fig. 2 ) indicated that structure (a) is correct. To confirm this, the F-diol was treated with sodium periodate (NaIO4) and then with sodium borohydride (NaBH4) followed by hydrolysis, which gave serine. Thus we confirmed that one peptide bond of I or II formed with the a-amino group of (3-hydroxyasparagine and the a-carboxyl group of O-methyl-L-tyrosine moiety, and that the other formed with the a-carboxyl group of (3-hydroxyasparagine and the a-amino group of L-tyrosine moiety.
From these results, the structures of I, II, D and F were deduced to be as shown in Fig. 1 . 
Discussion
OF4949-I and II each contained two unusual amino acids, ~-hydroxyasparagine and either 4-methylisodityrosine (B2) or isodityrosine (B1). (3-Hydroxyasparagine is one of the normal constituents of mammalian urine.4) OKAI found the spacial configuration of the natural product from human urine to be that of erythro-(3-hydroxy-L-asparagine.5) The ~-hydroxyasparagine moiety of I and II was the same optical isomer as that of urine. Isodityrosine coupled with two tyrosine units linked by diphenyl ether has been found in potato callus and in carrot cell walls.6,7) A few natural products, including piperazinomycin,8,9) cyclic hexapeptides RA,10,11> and bouvardin,12) have an analog of isodityrosine in their large cyclic structures.
When the aromatic proton lies over the other benzene ring at very close range as in the C5 proton 8 5.76 (IH, d, J=2.0 Hz) of piperazinomycin,9) the C6 proton 6 5.84 (1H, d, J=2.0 Hz) of acerogenin A,13,14) and the Tyr-63b proton 8 4.40 (1H, d, J=1.8 Hz) of bouvardin,12) it gives a signal much more upfield in the 1H NMR spectrum than ordinary aromatic protons. Therefore, the doublet proton signals (IH, d, J=2.0 Hz) at 3 5.83 of I and at the 5.78 of II are C5 protons.
The complete structure and the absolute configuration of I was confirmed by X-ray crystallographic analysis of its monobromo derivative.* Experimental General UV spectra were recorded on a Shimadzu double-beam UV-200 spectrophotometer, and IR spectra on a Hitachi 270-30 spectrophotometer.
Optical rotation was measured with a Jasco DPI181, and potentiometric titration was obtained with a Toa autotitrator HTS-10A. 13C (50.3 MHz) and 1H (200 MHz) NMR spectra were recorded on a Varian XL-200 . Secondary ion mass spectra were recorded on a Hitachi M-80A, and GC-MS measurements were done on a Hitachi M-70. Preparative HPLC was done on a Nucleosil 30C18 column (20 x 250 mm, Macherey Nagel Co.) or a Prep-PAK-500/C18 column (Waters Co.). For analysis, a Nucleosil 5C18 column (4 x 150 mm) or a ISC-09/ S2504 column (4 x 250 mm, Toyo Soda Mfg. Co.) was used and monitored by a Soma UV detector S-310 or flurometric reaction with o-phthalaldehyde (OPA 
Total Hydrolysis of I and II: Isolation of A, B1 and B2
A solution of I (200 mg) in 5 ml of 6 N HCl was heated at 100°C for 24 hours in a sealed tube. For separation of each amino acid, the residue was put on a Nucleosil 30C18 column and eluted with a 97.5:2.5 mixture of 0.1 M citrate buffer, pH 5.7, and acetonitrile. The fractions containing compound A were further purified on a Dowex 50W (H+) column by gradient elution with 0-1.0 N HCl, and on a Dowex 1 (formate-) column with 0.05 N formic acid, giving 63 mg of A as a colorless powder. The chromophoric amino acids B1 and B2 were separately chromatographed on a Dowex 5OW (H+) column with 1 N ammonia followed by desalting on a Nucleosil 30C18 column with H2O, giving 28 mg of B1 and 51 mg of B2.
II ( 3000, 1610, 1580, 1510, 1400, 1280, 1230, 1130, 1030 
TMS-A, TMS-B, and TMS-B2
A solution of A, B1, or B2 (0.5 mg) in a mixture of 0.1 ml of N,O-bis(trimethylsilyl)trifluoroacetamide (BSTFA) and 0.1 ml of acetonitrile was heated at 150°C for 15 minutes in a sealed tube. The reaction mixture was tested by GLC or GC-MS analysis.
B1-Methyl Ester and B2-Methyl Ester
First, 1 ml of SOCl2 was added dropwise into 10 ml of McOH cooled over a bath of ice and MeOH. After stirring it in the cold for 10 minutes, we added 74.6 mg of B1; then stirring was continued at room temperature overnight. The reaction mixture was chromatographed on a Nucleosil 30C18 column with 0.1 M citrate buffer -acetonitrile (82.8 :17.5) and desalted on a Diaion HP-20 column by gradient elution with H_O -MeOH, which gave 44.2 mg of B1-methyl ester as a colorless powder.
Then, B2 was esterified in the same way to give B2-methyl ester. B2-Methyl ester was also obtained from B1-methyl ester by reaction with CH2N2 in a mixture of MeOH and ether (1 : 1).
B1-Methyl Ester: IR (KBr) cm-1 3400, 2900 , 1735 , 1600 , 1500 , 1430 , 1280 , 1110 .
Reductive Cleavage of B2 To a solution of 3.0 mg of B2 and 2 ml of liquid ammonia being stirred over a bath of dry ice and acetone, we added 200 mg of metal sodium. Stirring was continued in the cold for 60 minutes; then the reaction mixture was purified on a Diaion HP-20 column with a gradient of H2O -50% MeOH, and monitored by HPLC on a Nucleosil 5C18 column (mobile phase, 2.5 % acetonitrile in 0.1 m citrate buffer, pH 5.7; flow rate, 0.5 ml/minutes; detection, at 275 nm). Fractions showing the same retention time (RI) as L-tyrosine (Rt, 5 .1 minutes) and O-methyl-L-tyrosine (Rt, 18 .2 minutes) were concentrated separately to give 1.0 mg and 0.8 mg of these amino acids, respectively. The optical configuration of both amino acids were found to be L by their 2,3,4,6-tetra-O-acetyl-Q-D-glycopyranosyl isothiocyanate (GITC) derivatives by the method of KINOSHITA et al.3~ Synthesis of B2 3-Bromo-L-tyrosine (2):15) L-Tyrosine (1, 9.05 g) was dissolved in 1.15 liters of 0.5 N HCl. A solution containing 2.8 g of KBrO3 and 11.9 g of KBr in 1 liter of H2O was added dropwise. The solution was concentrated and purified on a Diaion HP-20 column with 20% MeOH, giving 11.5 g of 2 as a colorless powder.
L-Tyrosine Methyl Ester (5): Compound 1 (19.0 g) was esterified with 3.9 ml of SOCl2 in MeOH in the same way as for B1-methyl ester to give 10.2 g of 5 as colorless needles.
Boc-3-bromo-L-tyrosine (3), Boc-L-tyrosine Methyl Ester (6) and Boc-B2: The preparation of 3 (10.4 g), 6 (8.5 g) and Boc-B2 (3.5 mg) was done by the method of NAGASAWA et a1.,16) with tert-butyl-(4,6-dimethylpyrimidyl-2-thiol)carbonate and triethylamine from 10.4 g of 2, 9.26 g of 5, and 3.8 mg of B2, respectively.
Boc-3-bromo-4-methoxy-L-phenylalanine Methyl Ester (4) and Boc-B2-methy Ester: Through a solution of 10.4 g of 3 or 3.5 mg of Boc-B2 in a mixture of McOH and ether (I : 1), we bubbled CH2N2 until the solution turned yellow. After being washed with 10% citrate, 4% NaHCO3, and water, in that order, the reaction mixture was chromatographed on a silica gel column with a mixture of benzene and CHCl3 (3: 7), which gave 8.5 g of 4 or 3.2 mg of Boc-B2-methyl ester.
Ullmann reaction17) between 4 and 6: A solution of 310 mg of 4 and 472 mg of 6 in pyridine (2.5 ml) was heated on an oil bath (145-. 150°C) with stirring under a nitrogen atmosphere in the presence of CuO (57.2 mg) and anhydride K2CO3 (1.5 g). After 4 hours, the reaction mixture was poured into CHCl3 (15 ml), and the resultant solution was washed with 2 % NaOH, 1 % HCl, and then water. The residue was chromatographed on a Nucleosil 5C18 column with 70% MeOH to give 7.2 mg of 7.
Compounds 7, 8 and 9 were analyzed by HPLC (Nucleosil 5C18 column; flow rate, 0.5 ml/minute; detection, at 275 nm) and TLC (silica gel; detection at 254 nm). They had the same Rt and Rf as Boc-B2-methyl ester, B2-methyl ester and B2, respectively. N-Formyl-II To a solution of 60 mg of 1 and 5 ml of 98 % formic acid being stirred over an ice bath, we added 5 ml of acetic anhydride. Stirring was continued in the cold for 30 minutes and then at room temperature for 60 minutes. The reaction mixture was purified on Nucleosil 30C18 with 0.1 M citrate buffer -acetonitrile (92.5 : 7.5) and desalted on HP-20 column, giving 24 mg of N-formyl-II as colorless needles: 1H NMR (CD3OD) 6 7.87 (1H, s, OHC-NH).
N-Formyl-I-methyl Ester and N-Formyl-II-methyl Ester A solution of 267 mg of N-formyl-II in a mixture of 20 ml of DMF, 200 mg of K2CO3, and 0.2 ml of methyl iodide was stirred at room temperature for 24 hours. The reaction mixture was neutralized with 2 N HCl, chromatographed on a Nucleosil 30C18 column with 0.1 M citrate buffer -acetonitrile (75:25), and desalted on an XAD-2 column to give 52.3 mg of N-formyl-II-methyl ester and 137.2 mg of N-formyl-I-methyl ester.
A solution of 42.2 mg of N-formyl-I-methyl ester in 4 N NaOH was stirred for 30 minutes at room temperature. After neutralization, the reaction mixture was desalted on a Diaion HP-20 column to give 3.9 mg of I.
N-Formyl-I-methyl Ester: 1H NMR (DMSO-d6) 6 3.72 (3H, s, COOCH3), 3.80 (3H, s, OCH3), 7.98 (1H, s, OHC-NH).
N-Formyl-II-methyl Ester: 1H NMR (DMSO-d6) 6 3.72 (3H, s, COOCH3), 7.94 (1H, s, OHC-NH).
Bromo-I To a solution of 1 (200 mg) dissolved in 20 ml of H2O was added 250 mg of N-bromosuccinylimide. This solution was stirred at room temperature for 60 minutes, and a few drops of 4 N ammonia were added to the reaction mixture, which was then chromatographed on a Nucleosil 30C18 column with 0.1 M citrate buffer -acetonitrile (85 :15) and desalted on an XAD-2 column to give 75.8 mg of bromo-I as a colorless columnar crystal:
Anal calcd for C23H25N4O8Br. H2O; C 47.35, H 4.67, N 9.60, found; C 46.91, H 4.93, N 9.57 
